Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending Topics
Diabetes
Clinical Development
Biologics
Fierce 50
Special Report
Awards Gala
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Trending T
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending Topics
Diabetes
Clinical Development
Biologics
Fierce 50
Special Report
Awards Gala
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
lung cancer
Biotech
Scorpion snaps up $150M series C to broaden clinical plans
As it broadens the clinical ambitions for its small molecule oncology programs, Scorpion Therapeutics has secured $150 million in financial fuel.
James Waldron
Jul 16, 2024 9:40am
FDA clears Galvanize's pulsed field ablation needle in cancer
May 28, 2024 2:05pm
Medtronic guided bronchoscopy on par with CT lung biopsy: study
May 23, 2024 1:25pm
Lung cancer startup Maverix Medical snaps up Cirrus Bio
Mar 29, 2024 12:55pm
Zymeworks halts phase 2 ADC plans over 'clinical landscape'
Mar 7, 2024 9:00am
FDA lifts hold on Iovance's lung cancer cell therapy trial
Mar 4, 2024 9:44am